- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04057404
Smartphone Twelve Lead Electrocardiogram Utility In ST Elevation Myocardial Infarction (ST LEUIS)
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Toward this objective, this study involves the following:
- Obtain simultaneous recordings of a standard 12-lead ECG and the iPhone "12-lead equivalent" ECG on patients presenting with chest pain in which the STEMI protocol was activated.
- Obtain simultaneous recordings of a standard 12-lead ECG and the iPhone "12-lead equivalent" ECG on patients presenting to the Emergency Department for evaluation of chest pain, not necessarily presenting with STEMI.
- Reading of ECGs (standard 12-lead and iPhone) by three independent cardiologists, who are blinded to the initial clinical ECG readings, the type of ECG equipment used, and the patient's clinical information.
- Assess the operational feasibility of using the Smartphone to obtain "12-lead equivalent" ECG recordings in patients suspected to have STEMI, and
- Determine the possibility of pooling the data obtained from this study with data from other institutions conducting identical studies, and developing a future IRB-approved protocol and statistical analysis plan to compare the sensitivity, specificity, positive predictive value and the negative predictive power of the iPhone ECG, using a paired standard 12-lead ECG as the gold standard.
There will be no therapeutic interventions. A single research-related procedure will be required, i.e. an iPhone ECG. Effort will be made to ensure that the performance of this procedure will not delay any treatment and/or diagnostic procedures that are part of usual or specialized care that the patient requires. Effort will be made to enroll 1 STEMI patient for every 2 non-STEMI patients.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73162
- Integris Baptist Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Male or female >= 18 years of age.
- Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures (patient or legally acceptable representative).
- Symptoms of chest pain upon presentation at the INTEGRIS Baptist Medical Center Emergency Department
Exclusion Criteria:
- Inability or refusal of the patient and/or the patient's legally-acceptable representative to provide written informed consent for any reason.
- Other conditions that in the opinion of the Principal Investigator or Co-Investigator(s) may increase risk to the subject and/or compromise the quality of the clinical trial.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Determine the number of agreements in diagnoses (STEMI vs. non-STEMI) between the standard 12-lead ECG and the iPhone "12-lead equivalent" ECG
Tidsramme: 10 Weeks
|
Number of Agreements
|
10 Weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- INT15-017
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Alivecor Heart Monitor
-
University at BuffaloAfsluttetArytmi, hjertebanken, svimmelhedForenede Stater
-
Massachusetts General HospitalUniversity of Massachusetts, WorcesterUkendtAtrieflimrenForenede Stater
-
Region GävleborgRekrutteringDiabetes mellitus | AtrieflimrenSverige
-
Cedars-Sinai Medical CenterAfsluttetKræftForenede Stater
-
NHS LothianAfsluttetAtrieflimren | Arytmier, hjerte | Takykardi, supraventrikulær | PræsynkopeDet Forenede Kongerige
-
Blackpool Teaching Hospitals NHS Foundation TrustUkendtHjertearytmiDet Forenede Kongerige
-
Mayo ClinicTrukket tilbage
-
AliveCorRekrutteringMyokardieinfarkt | Iskæmi | Myokardieiskæmi | Hjertesygdomme | Hjerte-kar-sygdomme | Karsygdomme | Hjertefejl | HjerteanfaldForenede Stater
-
Sarawak Heart CentreMinistry of Health, MalaysiaAfsluttetSlag | AtrieflimrenMalaysia
-
University of PittsburghBoston University; National Heart, Lung, and Blood Institute (NHLBI); Northeastern...AfsluttetPatologiske processer | Hjertesygdomme | Atrieflimren | Arytmi, Hjerte | Familiær atrieflimrenForenede Stater